awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36782767-2ACB0E2B-52D6-46C7-B1E5-6CCFBFC5466F
Q36782767-2ACB0E2B-52D6-46C7-B1E5-6CCFBFC5466F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36782767-2ACB0E2B-52D6-46C7-B1E5-6CCFBFC5466F
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.
P2860
Q36782767-2ACB0E2B-52D6-46C7-B1E5-6CCFBFC5466F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36782767-2ACB0E2B-52D6-46C7-B1E5-6CCFBFC5466F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64143031b27de2bba5795775968f04de90ff7285
P2860
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.